Attached files

file filename
EX-31.1 - EXHIBIT 31.1 - VIVEVE MEDICAL, INC.ex31-1.htm
EX-32.1 - EXHIBIT 32.1 - VIVEVE MEDICAL, INC.ex32-1.htm
EX-4.15 - EXHIBIT 4.15 - VIVEVE MEDICAL, INC.ex4-15.htm
EX-4.16 - EXHIBIT 4.16 - VIVEVE MEDICAL, INC.ex4-16.htm
EX-24.1 - EXHIBIT 24.1 - VIVEVE MEDICAL, INC.ex24-1.htm
EX-31.2 - EXHIBIT 31.2 - VIVEVE MEDICAL, INC.ex31-2.htm
EX-4.12 - EXHIBIT 4.12 - VIVEVE MEDICAL, INC.ex4-12.htm
EX-32.2 - EXHIBIT 32.2 - VIVEVE MEDICAL, INC.ex32-2.htm
EX-4.13 - EXHIBIT 4.13 - VIVEVE MEDICAL, INC.ex4-13.htm
EX-4.14 - EXHIBIT 4.14 - VIVEVE MEDICAL, INC.ex4-14.htm
EX-4.17 - EXHIBIT 4.17 - VIVEVE MEDICAL, INC.ex4-17.htm
EX-10.39 - EXHIBIT 10.39 - VIVEVE MEDICAL, INC.ex10-39.htm
10-K - FORM 10-K - VIVEVE MEDICAL, INC.vive20151231_10k.htm

Exhibit 23.1

 

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

 

 

We hereby consent to the incorporation by reference in the Registration Statements on Form S-8 (Nos. 333-206041, 333-201551, 333-153535, 333-127770, 333-106100, 333-91430, 333-57752, 333-51136, 333-48706, 333-37814, and 333-51547) of Viveve Medical, Inc. of our report (which contains an explanatory paragraph relating to the Company’s ability to continue as a going concern as described in Note 1 to the consolidated financial statements) dated March 24, 2016 relating to the consolidated financial statements, which appears in this Form 10-K.

 

/s/ Burr Pilger Mayer, Inc.

 

San Jose, California

March 24, 2016